Diabetes and Obesity

Over recent decades, the incidence of metabolic diseases such as obesity and diabetes has risen to epidemic proportions. Projections into the future suggest increasingly unmet patient needs and an unsustainable challenge for health care systems. Simultaneously, the drug discovery process is facing its own challenges. The number of pharmaceutical companies who are able to conduct expensive late stage clinical trials is declining. Funding for academic laboratories and biotechnology operations is limited. Novel strategies and new insights are needed to treat these diseases.

This EMBO | EMBL Symposium aims to bring together established experts, physician scientists and basic researchers to discuss the multi-layered and complex processes leading up to novel therapeutic strategies for diabetes, obesity and related health issues, such as cancer and cardiovascular disease, including:

•Mechanistic translational research addressing controversies of clinical relevance for diabetes and obesity
•Systems biology approaches dissecting multi-organ communication in the pathophysiology of metabolic disease
•Unraveling the emerging molecular interplays between immune processes and metabolic pathways
•Exploring novel insight into mechanisms of bariatric surgery and combination therapies for the development of future pharmacologics

+ show speakers and program
Richard DiMarchi, Indiana University, USA

Jeffrey Friedman, Howard Hughes Medical Institute, USA

Markus Stoffel, ETH Zuerich, Switzerland

Fredrik Bäckhed, Sahlgrenska University Hospital, Denmark

Matthias Blueher, University of Leipzig, Germany

Sadaf Farooqi, Cambridge Institute for Medical Research (CIMR), United Kingdom

Philippe Froguel, Imperial College London, United Kingdom

Lora Heisler, University of Cambridge, United Kingdom

Stefan Herzig, German Cancer Reserch Center, Germany

Tamas Horvath, Yale School of Medicine, USA

Gokhan Hotamisligil, Harvard School of Public Health, USA

Ron Kahn, Joslin Diabetes Center, USA

Christopher Karp, Cincinnati Obesity and Diabetes Centre (CDOC), USA

Sara Kozma, University of Cincinnati Medical Center, USA

Ruth Loos, Institute of Metabolic Science, United Kingdom

Jorge Moscat, Sanford Burnham Medical Research Center, USA

Martin Myers, University of Michigan, USA

Umut Ozcan, Harvard Medical School, USA

David Ron, University of Cambridge, United Kingdom

Philipp Scherer, UT Southwestern Medical School, USA

Randy Seeley, Cincinnati Obesity and Diabetes Centre (CDOC), USA

Bart Staels, University of Lille, France

Bernard Thorens, University of Lausanne, Switzerland

Mathias Treier, Max Delbrück Center for Molecular Medicine, Germany

Antonio Vidal-Puig, University of Cambridge, United Kingdom

Rudolf Zechner, University of Graz, Austria

Juleen Zierath, Karolinska Institutet, Sweden

13 Sep - 16 Sep 2012
meeting website